Taiwan Union Technology (6274) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
30 Jun, 2026Executive summary
Net revenue for 4Q25 reached NT$9,125 million, up 13.2% sequentially and 44.6% year-over-year.
Net income for 4Q25 was NT$1,084 million, an 8.1% increase from 3Q25 and 53.8% higher than 4Q24.
EPS for 4Q25 was NT$3.76, up 5.0% sequentially and 45.7% year-over-year.
Consolidated financial statements for 2025 and 2024 were audited and present fairly in all material respects, in accordance with IFRS and local regulations.
Revenue recognition from specific customers was a key audit matter due to its significant impact and inherent risk.
Financial highlights
Operating revenue for 2025 was $30,340,235 thousand, up 31.5% year-over-year from $23,070,425 thousand in 2024.
Net profit for 2025 was $3,409,149 thousand, up 31% from $2,604,368 thousand in 2024.
Gross margin for 4Q25 was 22.1%, down 1.7 percentage points from 3Q25 and 1.1 points from 4Q24.
Operating margin for 2025 was 14%, unchanged from 2024.
Basic EPS for 2025 was $12.13, up from $9.56 in 2024.
Segment performance
In 2025, ELL & SLL contributed 36% of CCL revenue, VLL & LL 32%, HDI & N-LL 24%, and Others 8%.
ELL & SLL segment grew 49% year-over-year, VLL & LL by 35%, HDI & N-LL by 3%, and Others by 49%.
Domestic sales and manufacturing contributed $12,549,729 thousand in segment profit, while overseas operations contributed $3,319,400 thousand in 2025.
Asia accounted for nearly all revenue, with $30,213,174 thousand in 2025.
Quarterly, ELL & SLL and VLL & LL segments maintained leading shares in CCL revenue.
Latest events from Taiwan Union Technology
- Net income and revenue surged year-over-year, driven by margin gains and a shift to advanced technologies.6274
Q2 202629 Jul 2026 - Revenue and profit surged, driven by HSD-Low Loss technology and margin improvements.6274
Q3 20241 Jul 2026 - Net profit up 216% YoY to NT$2.60 billion, EPS at NT$9.56, HSD-Low Loss tech at 66% of CCL revenue.6274
Q4 20241 Jul 2026 - Revenue and profit grew year-over-year, but margins and cash balances declined.6274
Q2 20251 Jul 2026 - Revenue and profit surged on strong overseas sales and HSD-Low Loss technology, despite negative free cash flow.6274
Q3 20251 Jul 2026 - Net income rebounded in Q1 2024 on strong revenue and margin gains, led by HSD-Low Loss growth.6274
Q1 20241 Jul 2026 - Strong revenue and profit growth, led by HSD-Low Loss technology and new bond issuance.6274
Q2 20241 Jul 2026 - Revenue up 44% and net profit up 49% year-over-year, with HSD-Low Loss products leading growth.6274
Q1 20251 Jul 2026 - Strong revenue and profit growth in Q1 2026, led by ELL & SLL, despite negative free cash flow.6274
Q1 202630 Jun 2026